About Angelman syndrome due to imprinting defect in 15q11-q13
Angelman syndrome due to imprinting defect in 15q11-q13 is a rare disease catalogued by Orphanet (ORPHA:411515). It is associated with the SNRPN, UBE3A, ATP10A genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Angelman syndrome due to imprinting defect in 15q11-q13 trials.
Search ClinicalTrials.gov for "Angelman syndrome due to imprinting defect in 15q11-q13" or filter by Orphanet code ORPHA:411515 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Angelman syndrome due to imprinting defect in 15q11-q13 trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Angelman syndrome due to imprinting defect in 15q11-q13. Updated daily.